期刊文献+

肺炎链球菌候选蛋白疫苗ClpP的保守性和抗原性 被引量:2

Conservation and antigenicity of Streptococcus pneumoniae vaccine candidate protein ClpP
下载PDF
导出
摘要 目的:评价酪蛋白裂解酶P(ClpP)作为候选疫苗的保守性和抗原性,分析在不同血清型肺炎链球菌(SPN)中的表达情况.方法:以TIGR4型SPN的ClpP基因序列设计引物,分别以12株不同血清型SPN的基因组DNA为模板,对ClpP基因进行聚合酶链反应(PCR)扩增、胶回收产物与PMD-18克隆载体连接后进行测序,运用生物信息学方法对其核苷酸及推测的氨基酸序列及抗原性进行分析,并利用West-ernBlot方法检测12株不同血清型SPN的ClpP蛋白的表达情况.结果:12株不同血清型SPN的ClpP基因序列和Gen-Bank数据库对已公布的TIGR4型SPN的ClpP基因一致性>99.0%,推测的氨基酸序列一致性>99.5%.WesternBlot结果显示anti-ClpP多克隆抗体与12型SPN的菌体蛋白能够起交叉反应.结论:ClpP蛋白在不同型SPN之间同源性高,在不同型SPN菌株中均有表达.ClpP是一个具有前景的SPN候选蛋白疫苗因子. AIM: To evaluate the conservation and antigenicity of Streptococcus (S.) pneumoniae vaccine candidate protein ClpP and analyze its expression in S. pnenmoniae of different serotypes. METHODS: For gene distribution analysis, the fulllength ClpP gene was amplified by PCR with genomic DNA from 12 different strains representing the 12 most important serotypes of S. pneumoniae in China. Gene-specific primers were designed according to the ClpP gene sequence of TIGR4 S. pneumoniae. The obtained PCR products were then cloned into PMD-18 vector and subsequently sequenced, followed by being analyzed through bioinformatics method. Moreover, Western Blot method was employed to demonstrate the expression of ClpP in different S. pneurnoniae serotypes. RESULTS: ClpP was sequenced from 12 tested strains and was found to be highly conserved, with 99.0% gene identity and 99. 5% predicted amino acids sequence identity. The antigen epitopes of ClpP were also found to be completely identical in different serotypes of S. pneumoniae using the antigenic software. In addition, the corresponding ClpP protein was found in all of the 12 tested strains using immunoblot analysis method. CONCLUSION: ClpP is highly conserved among all of the tested strains, thus making ClpP a promising candidate vaccine for single use or using in combination with other potential vaccine protein candidates.
出处 《第四军医大学学报》 北大核心 2008年第19期1741-1744,共4页 Journal of the Fourth Military Medical University
基金 国家自然科学基金(30400376)
关键词 肺炎链球菌 ClpP基因 序列分析 抗原性 Streptococcus pneumoniae ClpP, sequence analy-sis antigenicity
  • 相关文献

参考文献12

  • 1Bogaert D, Hermans PW, Adrian PV, et al. Pneumocoecal vaccines: An update on current strategies[ J]. Vaccine, 2004,22: 2209 - 2220.
  • 2Yu AY, Houry WA. ClpP: A distinctive family of cylindrical energy-dependent serine proteases [ J]. FEBS Lett, 2007,581 : 3749 -3757.
  • 3Kwon HY, Ogunniyi AD, Choi MH, et al. The ClpP protease of Streptococcus pneumoniae modulates virulence gene expression and protects against fatal pneumococcal challenge [ J ]. Infect Immun, 2004,72:5646 - 5653.
  • 4Butler SM, Festa RA, Pearce M J, et al. Self-compartmentalized bacterial proteases and pathogenesis [ J ]. Mol Microbiol, 2006,60: 553 - 562.
  • 5Moscoso M, Obregon V, Lopez R, et al. Allelic variation of polymorphic locus lytB, encoding a choline-binding protein, from streptococci of the mitis group[ J]. Appl Environ Microbiol, 2005,71 : 8706 - 8713.
  • 6Iannelli F, Oggioni MR, Pozzi G. Allelic variation in the highly polymorphic locus pspC of Streptococcus pneumoniae [ J ]. Gene, 2002,284:63 - 71.
  • 7Hollingshead SK, Becker R, Briles DE. Diversity of PspA : Mosaic genes and evidence for past recombination in Streptococcus pneumoniae[ J ]. Infect Immun, 2000,68:5889 - 5900.
  • 8Barocchi MA, Censini S, Rappuoli R. Vaccines in the era of genomics: The pneumococcal challenge [ J ]. Vaccine, 2007,25 : 2963 -2973.
  • 9Giefing C, Meinke AL, Hanner M, et al. Discovery of a novel class of highly conserved vaccine antigens using genomic scale antigenic fingerprinting of pneumococcus with human antibodies [J].J Exp Med, 2008,205 : 117 - 131.
  • 10Liu Y, Wang H, Chen M, et al. Serotype distribution and antimicrobial resistance patterns of Streptococcus pneumoniae isolated from children in China younger than 5 years [ J ]. Diagn Microbiol Infect Dis, 2008,61:256 -263.

二级参考文献9

  • 1Yother J,Johanna MW.Novel surface attachment mechanism of the streptococcus pneumoniae protein PspA[J].Infect Immun,1994,176(10):2976-2985.
  • 2Hava DL,Camilli A.Large-scale identification of serotype 4 streptococcus pneumonaie virulence factors[J].Mol Microbiol,2002,45(5):1389-1405.
  • 3Shaper M,Hollingshead SK,Benjamin WH,et al.PspA protects streptococcus pneumonaie from killing by apolactoferrin and antibody to PspA enhances killing of pneumococci by apolactoferrin[J].Infet Immun,2004,72(9):5031-5040.
  • 4Hava DL,LeMieux J,Camilli A.From nose to lung:the regulation behind streptococcus pneumoniae virulence factors[J].Mol Micro,2003,50(4):1103-1110.
  • 5Briles DE,Hollingshead SK,Nabors GS,et al.The potential for using protein vaccines to protect against otitis media caused by streptococcus pneumoniae[J].Vaccine,2000,19:S87-S95.
  • 6Baril L,Dietemann J,Essevaz-Roulet M,et al.Pneumococcal surface protein A (PspA) is effective at eliciting T cell-mediated responses during invasive pneumococcal disease in adults[J].Clin Exp Immunol,2006,145(2):277-286.
  • 7Brooks-Walter A,Briles DE,Hollingshead SK.The PspC gene of streptococcus pneumoniae encodes a polymorphic protein,PspC,which elicits cross-reactive antibodies to PspA and provides immunity to pneumococcal bacteremia[J].Infect Immun,1999,67(12):6533-6542.
  • 8Bosarge JR,Watt JM,McDaniel DO,et al.Genetic immunization with the region encoding the a-helical domain of PspA elicits protective immunity against streptococcus pneumonaie[J].Infect Immun,2001,69(9):5456-5463.
  • 9Bogaert D,De Groot R,Hermans PW.Streptococcus pneumoniae colonization:The key to pneumococcal disease[J].Lancet Infect Dis,2004,4(3):144-154.

共引文献3

同被引文献38

  • 1陈大鹏,尹一兵.生物源性基因疫苗的运送系统[J].生命的化学,2006,26(4):288-291. 被引量:2
  • 2胥文春,曹炬,许颂霄,罗进勇,朱旦,尹一兵.PspA免疫小鼠抗肺炎链球菌侵袭性感染研究[J].第四军医大学学报,2007,28(9):783-786. 被引量:4
  • 3Bogaert D, Hermans PW, Adrian PV, et al. Pneumococcal vaccines: An update on current strategies[J]. Vaccine, 2004,22:2209-2220.
  • 4Jedrzjas MJ. Pneumococcal virulence factors: Structure and function [ J ]. Microbiol Mol Biol Rev, 2001, 65 (2) : 187 - 207.
  • 5Ogunniyi AD, Grabowicz M, Briles DE, et al. Development of a vaccine against invasive pneumococcal disease based on combinations of virulence proteins of Streptococcus pneumoniae [ J ]. Infect Immun, 2007,75 ( 1 ) : 350 - 357.
  • 6Luo R, Mann B, Lewis WS, et al. Solution structure of choline binding protein A, the major adhesin of Streptococcus pneumoniae [J]. EMBO J, 2005, 24(1) :34 -43.
  • 7Miyaji EN, Dias WO, Tanizaki MM, et al. Protective efficacy of PspA (pneumococcal surface protein A)-based DNA vaccines: Contribution of both humoral and cellular immune responses [ J ]. FEMS Immunol Med Microbiol, 2003, 37( 1 ) :53 -57.
  • 8Ogunniyi AD, Woodrow MC, Poolman JT, et al. Protection against Streptococcus pneumoniae elicited by immunization with pneumolysin and CbpA [J]. Infect Immun, 2001, 69(10):5997-6003.
  • 9Robertson GT, Ng WL, Foley J, et al. Global transcriptional analysis of clpP mutations of type 2 Streptococcu.s pneumoniae and their effects on physiology and virulence [J]. J Bacteriol, 2002, 184(13),3508-3520.
  • 10Frees D, Savijoki K, Varmanen P, et al. Clp ATPases and ClpP proteolytic complexes regulate vital biological processes in low GC, Gram-positive bacteria[J]. Mol Microbiol, 2007, 63 (5) , 1285-1295.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部